Rituximab maintenance improves clinical outcome of relapsed/resistant follicular non-Hodgkin lymphoma in patients both with and without rituximab during induction: results of a prospective randomized phase 3 intergroup trial

MHJ van Oers, R Klasa, RE Marcus, M Wolf, E Kimby, RD Gascoyne, A Jack, MB (Mars) van t Veer, A Vranovsky, H Holte, M Glabbeke, I Teodorovic, C Rozewicz, A (Anton) Hagenbeek

Research output: Contribution to journalArticleAcademicpeer-review

568 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)3295-3301
Number of pages7
JournalBlood
Volume108
Issue number10
Publication statusPublished - 2006

Research programs

  • EMC MM-02-41-03

Cite this